1-4 September 2022 | Aalborg Denmark



Mads Albertsen

Aalborg University, Center for Microbial Communities

The research group of Mads Albertsen works in the interface of DNA sequencing, unculturable microbes and data science with the overall mission to populate the tree of life with genomes. They play with new sequencing technologies and develop novel high-throughput methods to extract and identify microbial genomes directly from metagenome sequencing of DNA. In 2020-2021 they redirected their research efforts to establish and run the national SARS-CoV-2 sequencing program in Denmark in collaboration with SSI and the Danish hospitals.


Hilmir Ásgeirsson

Senior Consultant and Specialist in infectious diseases and internal medicine
Department of Infectious Diseases, Karolinska University Hospital and Karolinska Institutet, Stockholm

Hilmir Asgeirsson is a senior consultant at the Department of Infectious Diseases at Karolinska University Hospital. His research interests have mostly been within the fields of tropical and travel medicine as well as on severe bacterial infections. Active in teaching at  undergraduate and postgraduate levels, and is responsible for national and international courses in tropical medicine. He is a member of the executive board of the International Society of Travel Medicine (ISTM) as well as being a member of the boards of the Swedish Society of Tropical Medicine and the Swedish Society of Travel Medicine.  


Bjørn Blomberg

Consultant physician, Associate professor 
Department of Medicine, Haukeland University Hospital and University of Bergen

Bjørn Blomberg is an infectious diseases clinician at Haukeland University Hospital and associate professor at the University of Bergen. He has done research on antimicrobial resistance in Tanzania with focus on the clinical impact in severe infections. He has worked on acute febrile illness in tropical settings, including sepsis, malaria and ebola. He has a broad interest in tropical diseases and has previously worked with the WHO global tuberculosis programme. Recently his research focus has been on longterm effects of COVID-19.


Jacob Bodilsen

Consultant, Ph.D., Associate professor
Department of Infectious Diseases, Aalborg University Hospital

Jacob Bodilsen is a consultant at the Department of Infectious Diseases at Aalborg University Hospital. His current research interests include epidemiological and clinical studies on brain abscess, viral and bacterial meningitis, encephalitis, and Lyme neuroborreliosis. In collaboration with other researchers, he is also developing a porcine model for pharmacokinetic studies of antimicrobials in brain infections as well as a brain abscess model.


Matthijs C. Brouwer

Neurologist, Medical Specialist, PhD Amsterdam
University Medical Centres, University of Amsterdam, Department of Neurology

I’m a neurologist specialized in infectious diseases of the nervous system working in the Amsterdam UMC (university medical centres), Amsterdam, the Netherlands. My clinical and research interests include diagnostics in CNS infections, bacterial meningitis, neurosarcoidosis, neurological complications of COVID19 infections and neuroborreliosis. Together with Diederik van de Beek I run the Amsterdam UMC neuro-infection laboratory in which 5 postdocs, 14 PhDs and 3 lab technicians  work on translational research projects.


Judith Bruchfeld

Senior consultant and associate professor
Department of Infectious Diseases, Karolinska University Hospital and Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet

Clinical TB expert and group leader for clinical tuberculosis (TB)research at Karolinska Institutet with extensive experience in leading large clinical studies with a focus on improvement of diagnostics for both active and latent TB as well as precision medicine for the handling of multidrug resistant TB through therapeutic drug monitoring. Promoter and co-founder of a multidisciplinary multiprofessional postCovid-19 clinic at Karolinska in 2020.  Serves as scientific expert for national and international health authorities in the field of TB and LongCovid.


Anders Fomsgaard

MD, DMSc, Professor
Statens Serum Institut (SSI), Univ. Southern Denmark

Chief of Virus R&D BSL3 Laboratory, SSI, CPH. Previous work: NIAID, NIH, USA; Max-Planck Inst. für Imunbiologi, Freiburg, and Univ Hospital CPH. Research area: molecular virology of exotic emerging zoonotic virus (EVD-LabNet ECDC). Infectious immunology versus DNA/mRNA vaccines for chronic hiv/siv (therapeutic vaccinations) and acute virus threats. Developments of novel metagenomic (array, WGS) and specific molecular methods for virus diagnostic and surveillance.


Niels Frimodt-Møller

Professor, MD, DMSc
Dept. of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark

MD in 1975, specialist in clinical microbiology 1986. Last position, head of department of clinical microbiology, Rigshospitalet 2014-19. Main research area in antibiotics i.e. activity in vitro and in vivo in experimental animal infection models, pharmacokinetics and pharmacodynamics, antibiotic resistance, monitoring of antibiotic consumption and resistance; urinary tract infections with focus on E. coli virulence, antibiotic resistance, treatment and epidemiology; S. aureus beta-lactamases and importance for beta-lactam susceptibility, bacteraemia and endocarditis.


Jan Gerstoft

Professor, overlæge, Dr. Med. 
Rigshospitalet infektions medicinsk klinik og Københavns Universitet institut for klinisk medicin, Denmark

Jan Gerstoft has been involved in HIV care since the reporting of the first European cases in 1981(published in 1982). He has particularly been interested in antiviral treatment, resistance to drugs including the epidemiology of resistant virus. He has served national and international board on treatment and resistance guidelines. With the Danish HIV cohort, he has delineated the life after successful antiviral treatment. Papers has been published in Science, NEJM, Lancet and BMJ among others.


Markus Göker

Privatdozent Dr. 
Leibniz Institute DSMZ — German Collection of Microorganisms and Cell Cultures GmbH

Markus Göker has established and is maintaining tools and databases for genome-based phylogeny and classification of prokaryotes, nomenclature of prokaryotes, virus phylogeny and classification and statistical analysis of phenotype microarray data. He currently also acts as Secretary of the Judicial Commission of the International Committee on Systematics of Prokaryotes (ICSP) and contributes to its publications, particularly regarding the International Code of Nomenclature of Prokaryotes (ICNP).


Henrik Hasman

Senior Scientist
Statens Serum Institut, Denmark

Henrik Hasman is part of the team conducting the national surveillance of carbapenemase producing organisms (CPO), Extended-Spectrum beta-lactamase (ESBL) producing E. coli and Vancomycin Resistant Enterococci (VRE) based on molecular genomics and epidemiology. The main interest is how to combine molecular typing methods with patient epidemiology to trace (and terminate) nosocomial outbreaks.


Mette Holm

Senior consultant, Associate professor, PhD
Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark

As a specialist of pediatric infectious diseases I clinically work with children and adolescents with infectious diseases including primary immunodeficiencies also known as inborn errors of immunity. Diagnostics and functional characteristics of these rare immune diseases is a research area of interest. The covid pandemic has increased the pediatric infectious disease network. The last two years my main research interests have been COVID-19 and the hyperinflammatory condition Multisystem Inflammatory Syndrome in Children (MIS-C) related to SARS-CoV-2 infection. Moreover, myopericarditis in children exposed to mRNA COVID-19 vaccine has been of interest. 


Astrid Iversen

Professor of Virology and Immunology
University of Oxford, UK

I am a Professor of Virology and Immunology at the University of Oxford and the Nuffield Department of Clinical Neurosciences at the John Radcliffe Hospital. I did my MD and PhD at the University of Copenhagen and was a postdoctoral fellow at Stanford University, USA. My primary research interests are in the pathogenesis of HIV-1 infection, particularly the interplay between host immune responses and viral evolution and how this knowledge may be translated into an HIV-1 vaccine. Understanding evolutionary adaptations that lead to immune escape in HIV-1 infection are also relevant for comprehending adaptive processes in other viruses, e.g., SARS-CoV-2.

Gunnar Kahlmeter

Gunnar Kahlmeter

MD, Ph.D. 
The European Committee on Antimicrobial sSusceptibility Testing (EUCAST).
Clinical microbiology, Kronoberg and Blekinge, Sweden.
Head of the Swedish Reference Laboratory for Phenotypic susceptibility testing.
Head of the EUCAST Development Laboratory, EUCAST

Gunnar Kahlmeter has been active in clinical microbiology since 1971. His main research and actions have been in the fields of antimicrobials, pharmacokinetics, susceptibility testing, standardisation, internal and external quality control, antimicrobial resistance surveillance, and standards committees on a national and international level. He developed EUCAST 2001 – 2012 and has continued to be responsible for developmental work, international standardisation, website development and upkeep and much more. Between 2012 and 2014 he was the president of ESCMID and for 10 years (2006 – 2016) he helped organise ECCMIDs across Europe. 


Mari Kanerva

Docent, specialist in infectious diseases and internal medicine
Head of Department, Infection Control Unit, Turku University Hospital, Finland

Mari Kanerva is an infection control specialist, working previously in Helsinki University Hospital, and since April 2022 in Turku University hospital unit of Infection Control and Hospital Hygiene. She has antimicrobial stewardship, patient safety issues and improved HAI prevention in the agenda. Her main research interest include HAI surveillance, MRSA, borreliosis and long covid.


Flemming Konradsen

Professor of Global Health, University of Copenhagen. Scientific Director of Global Health, Novo Nordisk Foundation. Director, School of Global Health, University of Copenhagen

Prof. Konradsen has more than twenty-five years of research and programming experience in the field of environmental health and global health. His research focuses on environmental health; pesticide poisoning; and control of infectious diseases in Asia, Africa and Europe. His research methods include epidemiology, qualitative studies, economic evaluations and health promotion. He has extensive experience from multidisciplinary community-based intervention research and is responsible for a number of programs aimed at building research capacity at university level in Asia and Africa. He has worked for international research organisations, the UN system, universities, development NGOs and national ministries of health.


Emil Loldrup Fosbøl

Senior Consultant in Cardiology (Overlæge)
The Heart Centre, Unit for valvular heart disease, Rigshospitalet, Denmark

Clinical epidemiology with a focus on cardiology and cardiovascular disease is Dr Fosbøl’s focus area. Valvular heart diseases and especially infective endocarditis are his main interests and he is the leading physician of the Department for valvular heart diseases at the University Hospital of Copenhagen, Rigshospitalet. He was recently invited by the European Heart Journal to write a State-of-the-art review on endocarditis surgery. Dr Fosbøl was part of the steering committee for the pivotal trial in endocarditis called POET and he is the chair of the ASTERIx trial testing surgery against medical therapy in endocarditis.

Jens Lundgren

Jens D. Lundgren

MD, DMSc, Professor
Rigshospitalet, University of Copenhagen
  • Professor of infectious diseases – Director of CHIP – Centre of Excellence for Health, Immunity and Infections, https://chip.dk/
  • Heads PERSIMUNE (Centre of Excellence for Personalised Medicine of Infectious Complications in Immune Deficiency), https://www.persimune.dk/
  • Initial focus in career on HIV. In recent years, focus expanded to include respiratory infections (e.g. influenza and recently SARS-CoV-2), and infections in patients with other types of immune dysfunction (incl transplantation, oncology, haematology, and treated patients with autoimmune disease).
Raquel Martin Iguacel

Raquel Martin-Iguacel

Consultant, associated professor
Infectious Diseases Department, Odense University Hospital

Dr. Raquel Martin-Iguacel is Senior Consultant in Infectious Diseases at the Odense University Hospital in Denmark and associate professor at the University of Southern Denmark. Her main line of research is within medical epidemiology, including  the Danish HIV cohort Study, cross matching to several other nationwide Danish registries with additional information on patient demographics, hospitalization, medical prescriptions and primary health care contacts. The focus of her research is HIV, especially late HIV presentation and opportunities for earlier HIV diagnosis in primary health care, and HIV and tuberculosis and other opportunistic infections.

Anna Teglund Norrby

Anna Norrby-Teglund

Karolinska Institutet, Stockholm, Sweden

Anna Norrby-Teglund is Professor in medical microbial pathogenesis and Director of the Center for Infectious Medicine at the Karolinska Institutet, Sweden. She has a long-standing interest in the pathogenesis of severe invasive bacterial infections. Her research has focused on delineating mechanisms contributing to severe manifestations of acute bacterial infections (i.e. sepsis, septic shock, necrotizing soft tissue infections) in order to identify novel targets for therapeutic intervention. The research has been translational in nature and based largely on patient materials and model systems that mimic the clinical setting. Recent and ongoing activities focus on personalized medicine in infectious diseases.

Niels Nørskov-Lauritsen

Professor, senior consultant, DMSc
Odense University Hospital, Denmark

My research interests focus on identification, classification and nomenclature of medical relevant bacteria, particularly Pasteurellaceae and Fusobacteriaceae. To this end, next generation sequencing has become an indispensable method. Another research area is mutational resistance to beta-lactam antimicrobials in Haemophilus influenzae. Concerning chronic infections, I have focused on Achromobacter from patients with cystic fibrosis. Concerning polymicrobial infections, a recent characterisation of spontaneous brain infections have promulgated Fusobacterium nucleatum-like bacteria to the same prominence as the widely recognized pathogen, the Streptococcus anginosus group. F. nucleatum-like bacteria must be further characterised.


Michael Bang Petersen

Department of Political Science, Aarhus University, Denmark

Michael Bang Petersen is a professor of political science at Aarhus University in Denmark. He specializes in political psychology and leads the HOPE-project, a large-scale research project on “How Democracies Cope with COVID-19”, covering the non-medical aspects of the corona crisis in Denmark and beyond. He is a member of the Danish Royal Society of Sciences and Letters and has received the Erik Erikson Award for early contributions to political psychology. During the COVID-19 pandemic, he has served as one of the main advisors on behavioral science to the Danish government and has been one of the most cited researchers in Danish media. 


Riina Richardson

Honorary Consultant Mycologist and Clinical Senior Lecturer in Infectious Diseases and Medical Education
Mycology Reference Centre Manchester and Department of Infectious Diseases, Wythenshawe Hospital, Manchester University NHS Foundation Trust; and Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, UK

Dr Riina Richardson is a Senior Clinical Lecturer in Infectious Diseases and Medical Education in the Division of Evolution, Infection and Genomics, University of Manchester and an Honorary Consultant Medical Mycologist at the Manchester University NHS Foundation Trust.

Dr Richardson is the Clinical Head of Service for the Mycology Reference Centre Manchester. She has expertise in medical microbiology, medical mycology, infectious diseases, antimicrobial stewardship and infection prevention, as well as mucosal immunology and oral and vaginal health and disease. She has a special interest in antifungal stewardship as well as acute invasive and chronic mucosal candidosis.

Dr Richardson’s research group undertakes basic research, applied laboratory work, and clinical studies and trials. Her main emphasis is on the pathogenesis of chronic mucosal infections as well as the carcinogenicity and mutagenicity of chronic Candida infections. To date she has published a total of over 170 peer-reviewed articles and books or book chapters and has an h-index of 43. She is the Lead for Infectious Diseases learning for Manchester Medical School and an Editor for Mycoses and the Journal of Fungi.


Lena Rós Ásmundsdóttir

MD, PhD, FRCPath
Landspitali University Hospital, Reykjavik, Iceland

I am a consultant medical microbiologist at Landspitali University Hospital in Reykjavik and Assistant Professor at the Faculty of Medicine, University of Iceland.  After completing my PhD focusing on invasive Candida infections I did specialist medical microbiology training (RCPath) in Edinburgh, Scotland. My main research interests are in the field of invasive fungal infections with focus on epidemiology, pathogenesis, molecular epidemiology and antifungal resistance. I have been a NSCMID board member since 2018.


Morten Ruhwald

MD, PhD | Director of TB Programme
FIND, the global alliance for diagnostics, Geneva, Switzerland

Morten Ruhwald, MD, PhD leads the TB programme at FIND in Geneva, Switzerland. Prior to joining FIND Morten was Chief Medical Officer at Statens Serum Institut in Copenhagen, Denmark where he oversaw the clinical development of TB and Chlamydia vaccines and specific skin tests for TB infection. At FIND Morten is responsible for a large portfolio of development projects and clinical trials spanning super simple point-of-care TB detection tests, tNGS, digital diagnostics and AI based tools. A key aim of the program is to develop and trial new non-sputum based tests and sampling strategies to prepare for the post pandemic recovery of TB programs in LMICs

Pierre Tattevin

Pierre Tattevin

MD, PhD (prof.)
Infectious Diseases & Intensive Care Unit, Pontchaillou University Hospital, Rennes, France

Prof. Pierre Tattevin, MD, PhD, is a 53-year-old infectious diseases  (ID) physician, trained in Paris (fellowship), Rennes (PhD), and San Francisco (post-doc). He was involved in the evaluation of antimicrobial agents for treatment of infective endocarditis (IE), in experimental model and in clinical trials. Past president of the French Society of Infectious Diseases (2018-2022), he currently chairs the Alliance for the Prudent Use of Antibiotics (APUA). He authored or co-authored >500 papers indexed in Pubmed, mostly as a first or last author. His H-index is 46.


Unnur Anna Valdimarsdóttir

Professor of Epidemiology
University of Iceland, Karolinska Institutet

Unnur A. Valdimarsdóttir, is a professor of Epidemiology at the University of Iceland, and adjunct professor at the Unit of Integrative Epidemiology, Karolinska Institutet. Her research program focuses on the bidirectional relationship between trauma/stress-related disorders and major somatic diseases, e.g. COVID-19. She has co-authored more than 200 scientific papers and as principal investigator received several international grants supporting her ongoing research, e.g. from the European Research Council (StressGene) and NordForsk (COVIDMENT).


Hege Vangstein Aamot

Researcher, PhD, Biomedical Laboratory Scientist
Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway

Dr Hege Vangstein Aamot has her background in molecular biology and she is a researcher at the Department of Microbiology and Infection Control, Akershus University Hospital, Norway. Her research focus on molecular epidemiology of infections using various molecular techniques for improvement of diagnostic, surveillance and prevention. Currently, she aims her attention at the use of next-generation sequencing techniques in these settings.


Arun Venkatesan

Department of Neurology, Johns Hopkins University School of Medicine

Arun Venkatesan, M.D., Ph.D. is a Professor at the Johns Hopkins University School of Medicine, in the Department of Neurology, Division of Neuroimmunology and Neurological Infections.  He serves as Director of the Johns Hopkins Encephalitis Center, a multidisciplinary clinical and research program devoted to delineating pathogenesis and optimizing diagnosis and management of patients with infectious and immune-mediated encephalitis.  His laboratory studies mechanisms of central nervous system injury in the setting of infection and neuroinflammation. He has received funding from the National Institutes of Health, Howard Hughes Medical Institute, National Multiple Sclerosis Society, and Maryland Stem Cell Research Fund.


Marjan Wouthuyzen-Bakker

dr., Infectious Disease Specialist
Department of Medical Microbiology and Infection Prevention, Netherlands

Dr. Marjan Wouthuyzen-Bakker is an internist-infectiologist and is working at the University Medical Center Groningen, in the Netherlands. Her main expertise is treating implant associated infections, like prosthetic heart valve endocarditis, vascular graft infections and periprosthetic joint infections. Marjan leads several international research projects, mainly in the field of periprosthetic joint infections, and published numerous articles in this field. She is the chair of the ESCMID European Study Group for Implant associated Infections (ESGIAI) and the Northern Infection Network of Joint Arthroplasty (NINJA). She is a board member of the European Bone and Joint Infection Society (EBJIS).

1-4 September 2022 | Aalborg Denmark

38th NSCMID Annual Meeting 2022